3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Neoplasms
1
Interventions
Paclitaxel
16
Carboplatin
14
Cisplatin
12
Oxaliplatin
9
Hyperthermic Intraperitoneal Chemotherapy
9
Cytoreduction Surgical Procedures
9
Fluorouracil
7
Bevacizumab
7
Doxorubicin
5
Leucovorin
4
Gemcitabine
4
catumaxomab
3
Docetaxel
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
nintedanib
2
liposomal doxorubicin
2
epothilone B
2
Surgical Procedures, Operative
2
Palliative Care
2
Mitomycin
2
Laparoscopy
2
Interviews as Topic
2
Drug Therapy
2
Blood Specimen Collection
2
veliparib
1
tremelimumab
1
talimogene laherparepvec
1
strattice
1
sodium thiosulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Peritoneal Neoplasms
×
phenoxodiol
×
Clear all
NCT00382811
2016-07-18
OVATURE
MEI Pharma, Inc.
Phase 3
Completed
142 enrolled